Topic:

April 2024

COVID-19 Prevention and Risks

Source:  (https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/prevention-risks.html)

How coronavirus spreads

Human coronaviruses cause infections of the nose, throat and lungs. They are most commonly spread from an infected person through:

  • respiratory droplets generated when you cough or sneeze
  • close, prolonged personal contact, such as touching or shaking hands
  • touching something with the virus on it, then touching your mouth, nose or eyes before washing your hands

Current evidence suggests person-to-person spread is efficient when there is close contact.

Difference between quarantine (self-isolate) and isolate

There is a difference between advice to quarantine (self-isolate) and advice to isolate. These measures are in place to protect the health and safety of Canadians.

Quarantine (self-isolate)

Quarantine for 14 days if you have no symptoms and any of the following apply:

  • you are returning from travel outside of Canada (mandatory quarantine)
  • you had close contact with someone who has or is suspected to have COVID-19
  • you have been told by the public health authority that you may have been exposed and need to quarantine

Isolate

You must isolate if any of the following apply:

  • you have been diagnosed with COVID-19, or are waiting to hear the results of a lab test for COVID-19
  • you have symptoms of COVID-19, even if mild
  • you have been in contact with a suspected, probable or confirmed case of COVID-19
  • you have been told by public health that you may have been exposed to COVID-19
  • you have returned from travel outside Canada with symptoms of COVID-19 (mandatory)

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Exploring Cognitive Fatigue and Brain Function in Lupus: New MRI Study Reveals Insights into Cognitive Impairment Mechanisms

Read

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Read